Financial basis

Nasal Cannulas Market Expected to Grow US $ 10,491.1 Million by End of 2028, According to Coherent Market Insights


SEATTLE, 22 December 2021 / PRNewswire / – According to Coherent Market Insights, the nasal cannula market is estimated to represent US $ 10,491.1 million in value by the end of 2028.

A nasal cannula is a medical device that delivers oxygen to the nose. Its design is relatively easy to clean and has a long lifespan if properly maintained. Nasal cannulas are used to deliver oxygen when a low flow, low or medium concentration is required and the patient is in a stable condition. Nasal cannulas use high flow oxygenation and a humidifier to deliver oxygen to the patient. The high-flow cannulas beat a certain resistance of the expiratory flow, causing an increase in airway pressure. This increase in airway pressure is evident in the neonatal model without a pressure relief valve. To avoid infection, patients should thoroughly clean the cannula tube before using it. To ensure that the cannula is sterile and free from bacteria, it should be cleaned with white vinegar and lukewarm water. The vinegar kills bacteria but does not eat into the material of the tube. Then the cannula should be rinsed with cold water to remove soap and bacteria. Then the cannula should be dried before use. Changing cannulas is essential for patients with respiratory ailments.

Request a copy of this report @

Market factors:

The high prevalence of asthma is expected to propel the growth of the global nasal cannulas market during the forecast period. For example, according to The Global Asthma Report 2018, the prevalence of asthma symptoms was 23% and the prevalence of a medical diagnosis of asthma was 12% in Brazil.

Market opportunities:

The increased production capacities are expected to provide lucrative growth opportunities for players in the global market. nasal cannula market. For example, in june 2020, Vapotherm, Inc. has expanded its capital equipment manufacturing capabilities to enable the company to increase production of its Precision Flow systems up to 20 times above pre-COVID pandemic levels. 19.

Market trends:

Latin America The global nasal cannula market is expected to experience significant growth owing to the high prevalence of chronic restorative diseases. For example, according to Globocan 2018, Brazil recorded 559,371 new cases of lung cancer in 2018. According to the study “Chronic Obstructive Pulmonary Disease in Latin America‘, Posted in January 2019 in the journal Annals of Global Health, the prevalence of COPD in Latin American cities ranged from 6.2 to 19.6% among people aged 40 and over.

The emergence of Covid-19 has led to an increase in the adoption of the nasal cannula. Globally, since 17:14 CET, December 17, 2021, there have been 271,963,258 confirmed cases of COVID-19, including 5,331,019 deaths, reported to the WHO. From December 16, 2021, a total of 8,337,664,456 doses of vaccine were administered.

Buy the full report now @

Competitive landscape:

The major players operating in the global nasal cannula market are Allied Healthcare Products, Besmed Health Business Corp., Drive Devilbiss International, Edward LifeSciences Corp., Fairmont Medical, Flexicare Medical, Medtronic plc., Maquet Holding BV & Co. KG, Medin Medical Innovations, Salter Labs, Sorin Group, Smiths Medical, Terumo Corporation, Teleflex Incorporated, Vapotherm Inc. and Well Lead Medical Co. Ltd.

Market segmentation :

On the basis of product type, the global nasal cannula market is segmented into:

  • Curved tip cannula
  • Flared cannula
  • Straight claw cannula
  • Cannula with curved and flared claws

On the basis of material, the global nasal cannula market is segmented into:

On the basis of applications, the global nasal cannula market is segmented into:

  • Asthma
  • Lung cancer
  • Chronic bronchitis
  • Pulmonary embolism
  • COPD
  • Emphysema
  • Cystic fibrosis
  • Pneumonia

On the basis of end user, the global nasal cannula market is segmented into:

  • Hospital
  • Long-term care center
  • Home care settings
  • Ambulatory surgery centers
  • Others

On the basis of, the global nasal cannula market is segmented into:

  • North America
  • Latin America
    • Argentina
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC countries
    • Rest of Middle East
  • Africa
    • North Africa
    • central Africa
    • South Africa

Need a personalized report? Please visit @

More relevant trend reports can be found below:

Nasal Tear Stents Market, by product type (bichannel stent and monocanalicular stent), by application (epiphora, dacryocystorhinostomy (DCR) and congenital nasolacrimal obstruction) end user (hospitals and ophthalmic surgery centers) and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook and Opportunity Analysis, 2019 – 2027

COVID-19 Nasal Swab Testing Market, by product type (foam-tipped, non-woven and other swabs), by diagnostic type (molecular diagnostics, CRISPR and biosensors and others), by mode (point of service and non-point of service), by End user ( hospital and clinic, laboratories and diagnostic centers and others) and by region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Analysis of size, share, outlook and opportunities, 2021 – 2028

About Us:

Consistent market information is a global market intelligence and consulting organization that aims to help our plethora of clients achieve transformational growth by helping them make critical business decisions. We are based in India, having a global finance capital sales office in the United States and sales consultants in UK and Japan. Our clientele includes players from various industries in more than 57 countries around the world. We create value for our clients through our highly reliable and accurate reporting. We are also committed to playing a leading role in providing insight into various post-COVID-19 sectors and continue to deliver measurable and sustainable results to our clients.

Contact us:

Mr. Shah
Senior Client Partner – Business Development
Consistent market information
we: + 1-206-701-6702
UK: + 44-020-8133-4027
Japan: + 81-050-5539-1737
India: + 91-848-285-0837
E-mail: [email protected]
Follow us: LinkedIn | Twitter

SOURCE Consistent market insights